AINDEX
Markets

Phibro Animal Health Corporation (PAHC)

PAHCNASDAQ-GMBiotechnology: Pharmaceutical Preparations

$35.02

-0.9500 (-2.64%) today

At the close, Nov 16, 4:00 PM ET. After hours $35.02 –

-2.64% 1D
Market cap
$1.42bn
P/E
10.7
EPS, last 4 quarters
$3.27
Dividend yield
1.33%
Day range
$34.83 to $36.07
52-week range
$28.25 to $60.08
Average volume
–
Previous close
$35.97

Analysts

2 covering

Hold1 buy, 0 hold, 1 sell

Targets a year out average $45.00, +28.5% from here

$35.00now $35.02$55.00

Earnings

next estimate $0.9400

Next report

Dec 2025

+26.1%

Mar 2026

+5.6%

Jun 2026

+18.1%

Sep 2026

0.0%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$373.91m$383.54m$396.75m$386.77m
Gross profit$132.66m$125.67m$134.40m$128.54m
Operating income$50.33m$44.65m$48.16m$49.64m
Net income$27.46m$24.02m$21.71m$29.52m

Last four quarters: revenue $1.54bn, margin 6.7%, free cash flow $21.67m

News

8 latest

The company

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-GM
Region
North America
Website
pahc.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.